Today were reported iShares S&P Global Healthcare Sect.(ETF) (NYSEARCA:IXJ)‘s daily net flows. The ETF registered $-132.22M asset outflows for -9.24% decrease, reaching $1298.58M after yestarday’s trading session. The chart of iShares S&P Global Healthcare Sect.(ETF) shows negative short-term setup. In the net flows calculation is not included the performance of the etf but only share redemptions (outflows) and share purchases (inflows). Net outflows leads to less cash for managers to invest, which theoretically decreases demand for the etf’s holdings. The ETF increased 3.49% or $3.3 on November 9, hitting $97.89. It is down 0.72% since April 8, 2016 and is downtrending. It has underperformed by 6.37% the S&P500.
The ETF’s YTD performance is -7.69%, the 1 year is -7.32% and the 3 year is 6.29%.
The ETF’s average P/E ratio is 20.09, the price to book is 3.12, the price to sales is 2 and the price to cashflow is 13.9. iShares S&P Global Healthcare Sect.(ETF) is in the ETF category: , is part of the fund family and currently has $ net assets. It was started on 1/1/0001. The fund’s top holdings are: Johnson & Johnson Common Stock for 8.24% of assets, Pfizer Inc. Common Stock for 5.06%, NOVARTIS AG CHF0.50 (REGD) for 4.91%, Merck & Company Inc. Common St for 4.25%, ROCHE HLDGS AG GENUSSCHEINE NPV for 4.24%, UnitedHealth Group Incorporated for 3.49%, Medtronic plc. Ordinary Shares for 2.96%, Amgen Inc. for 2.84%, Gilead Sciences Inc. for 2.55%, GlaxoSmithKline PLC for 2.51%. The ETF sector weights are: Basic Materials 0.26%, Healthcare 97.58%, Industrials 1.24%, Technology 0.91%. The ETF currently as 0% yield.
More notable recent iShares S&P Global Healthcare Sect.(ETF) (NYSEARCA:IXJ) news were published by: Benzinga.com which released: “Are Global Health Care ETFs Worth Prescribing?” on February 22, 2013, also Nasdaq.com with their article: “Mid-Day ETF Update: ETFs, Stocks Higher as U.S. Election Underway” published on November 08, 2016, Benzinga.com published: “Are We Seeing A Sector Rotation Away From Financials And Into Healthcare?” on May 05, 2016. More interesting news about iShares S&P Global Healthcare Sect.(ETF) (NYSEARCA:IXJ) were released by: Etftrends.com and their article: “Behind the Stellar run for Healthcare ETFs” published on April 10, 2015 as well as Cnbc.com‘s news article titled: “The case for buying biotech stocks ahead of the election” with publication date: November 07, 2016.
IXJ Company Profile
iShares S&P Global Healthcare Sector Index Fund (the Fund) seeks investment results that correspond generally to the price and yield performance of the Standard & Poorâ€™s Global Healthcare Sector Index (the Index). The Index is a subset of the Standard & Poorâ€™s Global 1200 Index, and measures the performance of companies that Standard & Poorâ€™s deems to be a part of the healthcare sector. Component companies include healthcare providers, biotechnology companies, and manufacturers of medical supplies, advanced medical devices and pharmaceuticals.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.